Literature DB >> 20870082

Focal therapy meets prostate cancer.

Massimo Lazzeri1, Giorgio Guazzoni.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20870082     DOI: 10.1016/S0140-6736(10)60594-6

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  4 in total

1.  High PCA3 scores in urine correlate with poor-prognosis factors in prostate cancer patients.

Authors:  Wei Wei; Jiangyong Leng; Hongxiang Shao; Weidong Wang
Journal:  Int J Clin Exp Med       Date:  2015-09-15

2.  Current Challenges in Prostate Cancer Management and the Rationale behind Targeted Focal Therapy.

Authors:  Al B Barqawi; Kevin J Krughoff; Khadijah Eid
Journal:  Adv Urol       Date:  2012-05-10

3.  Prostate Cancer Claims for a Personalized Medicine.

Authors:  Massimo Lazzeri
Journal:  N Am J Med Sci       Date:  2015-10

4.  The role of targeted focal therapy in the management of low-risk prostate cancer: update on current challenges.

Authors:  Daniel W Smith; Diliana Stoimenova; Khadijah Eid; Al Barqawi
Journal:  Prostate Cancer       Date:  2012-12-31
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.